Skip to main content
. 2021 Jan 11;11(1):e041460. doi: 10.1136/bmjopen-2020-041460

Table 2.

Prescriber and general practice characteristics

Individual characteristics General practice characteristics
Participant no. Gender Employer and work location Years since registration Years since qualifying as independent prescriber Practice list size Indices of multiple deprivation decile*
General practitioners
P10 F Practice, England (West) 20 5000–≤10 000 ≤5
P12 M Practice, England (South West) 36 5000–≤10 000 >5
P13 F Practice, Scotland 26 5000–≤10 000 >5†
P14 F Practice, England (South West) 31 5000–≤10 000 >5
P16 F Practice, England (South West) 26 >10 000 >5
P18 F Practice, England (Midlands) 12 5000–≤10 000 ≤5
Practice-based pharmacists
P3 M Practice, England (South) >10 >5 >10 000 >5
P9 M Group of four practices, England (London) <10 ≤5 <5000 ≤5
>10 000 >5
>10 000 <5
>10 000 <5
P11 M Practice, England (West) <10 ≤5 >10 000 >5
P22 M Practice, England (South) >10 ≤5 >10 000 ≤5
P29 F Practice, England (East) <10 ≤5 >10 000 >5
P32 M Community pharmacy/practice, England (South) >10 ≤5 5000–≤10 000 >5
Nurses
P5 F Practice, Wales >10 >5 >10 000 >5†
P1 M Practice, England (West) >10 >5 >10 000 >5
P15 F Practice, England (West) >10 >5 >10 000 >5
P19 F Practice, England (Midlands) >10 >5 >10 000 ≤5
P21 F Practice, England (South) >10 ≤5 >10 000 >5

P9 worked in four practices; P3 and P21 worked in the same practice.

All PBPs and nurses were independent prescribers.

*Information from National General Practice Profiles41 (lower numbers indicate more deprivation).

†Derived from participant’s depiction of patient population.